Experience

Volastra Therapeutics
• United States
• Biotechnology
• 1 - 100 Employee
• Senior Scientist

  • Jun 2022 - Present

Mnemo Therapeutics
• France
• Biotechnology Research
• 1 - 100 Employee
• Scientist

  • Jan 2022 - May 2022


Institut Curie

• France
• Hospitals and Health Care
• 700 & Above Employee

• Postdoctoral Researcher

  • 2013 - 2020

  Spearheaded research on epigenetic regulation of transposable element (TE) expression and its impact on natural innate immune responses in myeloid cells. Pioneered new molecular techniques to measure the interaction of TEs with innate immune senors. Our work suggests that natural innate immune responses are driven in part by detection of transposable elements, in particular LINE1, as a countermeasure to broaden and strengthen responses to pathogen. Spearheaded research on epigenetic regulation of transposable element (TE) expression and its impact on natural innate immune responses in myeloid cells. Pioneered new molecular techniques to measure the interaction of TEs with innate immune senors. Our work suggests that natural innate immune responses are driven in part by detection of transposable elements, in particular LINE1, as a countermeasure to broaden and strengthen responses to pathogen.